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Lipid raftsUsing phase contrast and ﬂuorescence microscopy we study the inﬂuence of the alkylphospholipid, ALP,
10-(octyloxy) decyl-2-(trimethylammonium) ethyl phosphate, ODPC, in giant unilamellar vesicles, GUVs,
composed of DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), brain sphingomyelin (SM) and cholesterol
(Chol). The results show that adding 100 μM ODPC (below CMC) to the outer solution of GUVs promotes
DOPC membrane disruption over a period of 1 h of continuous observation. On the other hand, the presence
of SM and Chol in homogeneous ﬂuid lipid bilayers protects the membrane from disruption. Interestingly, by
adding 100 μM ODPC to GUVs containing DOPC:SM:Chol (1:1:1), which display liquid ordered (Lo)–liquid
disordered (Ld) phase coexistence, the domains rapidly disappear in less than 1 min of ODPC contact with the
membrane. The lipids are subsequently redistributed to liquid domains within a time course of 14–18 min,
reﬂecting that the homogenous phase was not thermodynamically stable, followed by rupture of the GUVs. A
similar mechanism of action is also observed for perifosine, although to a larger extent. Therefore, the initial
stage of lipid raft disruption by both ODPC and perifosine, and maybe other ALPS, by promoting lipid mixing,
may be correlated with their toxicity upon neoplastic cells, since selective (dis)association of essential proteins
within lipid raft microdomains must take place in the plasma membrane.
© 2013 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Alkylphospholipids (ALPs) are structurally related to a naturally
occurring phospholipid, 2-lysophosphatidylcholine (lysolecithin, LPC),
and present promising cytotoxic effects on different neoplastic cell
lines. ALPs act preferably on the cell membrane rather than DNA [1].
There is increased interest in their biological activity because they are
able to induce apoptosis in tumor cells and may serve to complement
existing DNA directed anticancer chemotherapies [2]. Among the
mostwell-knownALPs are edelfosine [3], miltefosine [4], and perifosine
[5].
It has been shown that alkylphospholipids accumulate in cell mem-
branes, resist cell lipases, interfere with lipid-based signal transduction
as well as with phospholipid biosynthesis [6], which leads to apoptosis,
inhibit neovascularization, prevent invasion and induce tumor cell
differentiation [7]. Edelfosine may exert its pro-apoptotic effect by acti-
vation of Fas/CD95 [8] while perifosine may induce cell cycle arrest
and apoptosis in human carcinoma cell lines by blocking the AKT+55 11 30916749.
evier OA license.phosphorylation [9]. It has also been proposed that edelfosine affects
the protein composition of lipid rafts in yeast [10] and leukemic cells
[8,11], in which the amount of cholesterol plays an important role.
ALPs may use lipid rafts for cellular internalization and to inhibit phos-
phatidylcholine synthesis to varying degrees, acting as gateways to in-
duce apoptosis in lymphoma and leukemic cells [12,13].
Lipid rafts are highly ordered membrane domains enriched in cho-
lesterol, sphingolipids and proteins,whichparticipate in diverse cellular
processes such as signal transduction and lipid trafﬁcking [14]. Lipid
rafts display lateral liquid ordered (Lo)–liquid disordered (Ld) phase
separation in themembrane plane on the order of hundreds of nanome-
ters in living cells [15]. They can also be observed as microscopic
domains in isolated membrane systems [16,17]. Certainly, molecules
that affect lipid phase separation may have important effects on physi-
ological responses.
The alkylphospholipid 10-(octyloxy) decyl-2-(trimethylammonium)
ethyl phosphate, ODPC (Fig. 1), originally synthesized by Agresta et al.
[18], showed cytotoxic effects on some cancer cell lines comparable to
others ALPs, but with lower hemolytic activity and cytotoxicity. In partic-
ular, we demonstrated that ODPC (10–50 μM) leads to apoptosis and in-
hibits the proliferation of leukemia cells, sparing normal hematopoietic
Fig. 1. Chemical structures of (a) ALPs: 10-(octyloxy) decyl-2-(trimethylammonium)
ethyl phosphate (ODPC) and Perifosine (Per), and (b) lipids: 1,2-dioleoyl-sn-glycero-
3-phosphocholine (DOPC), brain sphingomyelin (SM) and cholesterol (Chol).
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protein associated with lipid rafts in its palmitoylated form, takes place
in the lipid raft enriched fraction of leukemia cells within 3 h after treat-
ment with 25 μM ODPC [20].
In order to better understand the role of lipid rafts in the mecha-
nism of action of ODPC, we used model membranes constituted by
giant unilamellar vesicles, GUVs, and investigated how the lipid
membrane responds to the addition of ODPC in the outer GUVs
solution. We show that the main effect of ODPC, at concentrations
below cmc, is to promote membrane disruption with time on binary
systems composed of an unsaturated lipid DOPC and Cholesterol
(Chol) and DOPC and Sphingomyelin (SM) to a lesser or to a greater
extent depending on the membrane composition. On the other hand,
ODPC does not affect the membrane integrity of GUVs composed of a
homogeneous mixture of DOPC:Chol:SM, but is indeed able to disrupt
the lipid domains by favoring lipid mixing until the complete abolish-
ment of the phase separation. Further, this striking effect is compared
with that promoted by perifosine on Ld–Lo phase coexistence.2. Material and methods
2.1. Materials
The lipids DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), brain
sphingomyelin (SM), cholesterol (Chol), and the ﬂuorescent label
Rhodamine-DOPE [1,2-dioleoyl-sn-glycerol-3phosphoethanolamine-N-
(lissamine rhodamine B sulfonyl)] (Rh-DOPE) were purchased
from Avanti Polar Lipids (Alabaster, AL). The respective chemical
structures are given in Fig. 1. The ALP ODPC, 10-(octyloxy) decyl-2-
(trimethylammonium) ethyl phosphate, was synthesized as previously
described [18,19] whereas perifosine (Per) was purchased from SelleckChemicals (Houston, TX, USA). Their chemical structures are also repre-
sented in Fig. 1.
2.2. Methods
2.2.1. Giant unilamellar vesicles preparation
Giant unilamellar vesicles (GUVs) were prepared by the electro-
formation procedure [21] and were composed of pure DOPC and mix-
tures of DOPC:Chol (8:2), DOPC:SM (8:2) and DOPC:SM:Chol (6:1:3)
and (1:1:1). The latter composition is known to exhibit Lo–Ld phase
separation at 22 °C [22]. Brieﬂy, ~20 μl of 2 mg/ml lipid chloroform
solution of desired composition was spread on the surfaces of two
conductive glass slides coated with indium tin oxide. We investigated
the lipid compositions of DOPC:SM:Chol containing up to 0.2 mol% of
the ﬂuorescent Rhodamine-DOPE (Rh-DOPE), which is known to pref-
erentially concentrate in the liquid disordered phase (Ld) [23]. The
glass slides were placed with their conductive sides facing each other
and separated by a 2 mm thick Teﬂon® frame. The chamber was ﬁlled
with 0.2 M sucrose solution and placed inside an oven at ~55 °C. The
glass plates were connected to a function generator and an alternating
current of 2 V with a 10 Hz frequency was applied for 2 h. The GUVs
were observed the following day, allowing the vesicles to reach their
thermodynamic equilibrium completing the phase separation process.
The vesicles were then diluted in 0.2 M glucose containing the desired
amount of ODPC and immediately observed in the optical microscopy.
The osmolarities of the sucrose and glucose solutions were measured
with a cryoscopic osmometer Osmomat 030 (Gonotec, Germany) and
carefully matched to avoid osmotic pressure effects. All measurements
were done at room temperature (22–25 °C).
2.2.2. Optical microscopy observation
Vesicles were observed in the phase contrast mode by means of an
invertedmicroscope Axiovert 200 (Carl Zeiss; Jena, Germany) equipped
with a PlanNeo-Fluar 63× Ph2 objective (NA 0.75) and A-plan 10× Ph1
(NA 0.25). Images were recorded with an AxioCam HSm digital camera
(Carl Zeiss). A ﬁlter with excitation at 538–563 nm and emission at
570–640 nm (Zeiss ﬁlter set 43 HE) and a mercury lamp HXP-R
120 W were used for observing vesicles labeled with Rh-DOPE in the
ﬂuorescence mode.
3. Results and discussion
In order to understand how ODPC interacts with lipid membranes,
giant unilamellar vesicles, GUVs, containing DOPC, SM and Chol were
used to mimic the outer hemilayer of the plasma membrane. Time
evolution of GUV morphology was followed by video microscopy
after incubation in glucose solutions containing ODPC at concentra-
tions below cmc [19]. We ﬁrst describe the responses observed by
phase contrast and ﬂuorescence microscopy from GUVs containing
DOPC, binary mixtures of DOPC:Chol (8:2) and DOPC:SM (8:2) and
ternary mixtures of DOPC:SM:Chol (6:1:3). All these compositions
correspond to homogeneous lipid mixtures in Lo phases [22]. Then,
we will consider the effect of 100 μMODPC in a membrane containing
DOPC:SM:Chol (1:1:1) that displays Lo–Ld phase separation [23]. The
latter results are compared with those promoted by 100 μM perifosine.
3.1. Homogenous lipid mixtures in ﬂuid phases
GUVs of DOPC and mixtures containing Chol and SM are spherical,
exhibiting usually small undulations typical of ﬂuid-like membranes
[22,24,25]. The inﬂuence of ODPC was investigated at increasing con-
centrations. We observed that ODPC at concentrations less than
50 μM did not modify the lipid bilayers for all studied homogeneous
mixtures during 1 h of continuous observation. On the other hand,
we observed that a percentage of GUVs of DOPC were not altered
while a signiﬁcant number of them suddenly burst when they























Fig. 2. Stability of GUVs composed of DOPC, DOPC:Chol (8:2), DOPC:SM (8:2) in contact
with an outer solution containing 100 μM ODPC. The number of GUVs that remained
intact was counted over time. The error bars correspond to the standard deviations of ex-
periments done in triplicate. 100 GUVs were inspected for each membrane composition
from each experiment.
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percentage of GUVs that exploded with time increased with ODPC
concentration. Furthermore, we also noted that ODPC exerted a sim-
ilar effect on membranes containing 20 mol% of either SM or Chol,
although to a lesser extent. Fig. 2 presents a comparison of the num-
ber of GUVs that remained unaltered with time in the presence of
100 μM ODPC, as an example, for membranes of DOPC and the binary
mixtures.
As one can note, only circa 60% and 30% of GUVs composed of pure
DOPC remained intact under the inﬂuence of 100 μM ODPC after
30 min and 1 h of incubation time, respectively (Fig. 2). Moreover,
ODPC is less effective in disrupting DOPC bilayers containing a certain
amount of SM and Chol. Note that SM is indeed more effective than
Chol in protecting the membrane from the effect of ODPC for longer
periods. It is worth noting that experiments of carboxyﬂuorescein
leakage from large unilamellar vesicles, LUVs, composed of saturated
lipidDPPC revealed that circa 60% of LUVs suffer rupture in the presence
of 100 μM ODPC [19]. Such an effect was 4-fold less efﬁcient in LUVs
composed of DPPC:Chol (6:4) [19]. As one can see, ODPC (Fig. 1) struc-
turally resembles DOPC and DPPC, so that it has the same polar head
and a single long apolar hydrophobic chain. This similarity must facili-
tate its insertion into the membrane due to a favorable afﬁnity. Once
inserted, it can accumulate in the outer membrane causing an increase
in the membrane tension. This would result in membrane destabiliza-
tion and rupture. In fact, calorimetric data from LUVs of DPPC revealed
a decrease of the liquid-to-gel transition temperature upon ODPC inter-
action [19], which is theoretically correlated to an increase in the
membrane tension [26]. On the other hand, if ODPC is able to perform
a ﬂip–ﬂop from the outer to the inner leaﬂet, it can promote aa
Fig. 3. GUVs composed of DOPC:SM:Chol (1:1:1) and labeled with 0.2 mol% of Rh-DOPE: (a) p
preferentially into the liquid disordered phase [23]. Objective 60×. The scale bar correspondsmembrane solubilization via a detergent-like mechanism [27]. The
presence of Chol and SM in the PC-membranes prevents somehow the
GUV destabilization. Previous study focused on the interaction of up
to 20 mol% of edelfosine on large multilamellar vesicles composed of
DOPC:SM (1:1) by DSC demonstrated that this lipid analog may have
interaction with both phospholipids, but no membrane destabilization
has been reported [10].
Surprisingly, the interaction between 100 μMODPC and the ternary
mixture of DOPC:SM:Chol (6:1:3) did not destabilize the membrane
over a period of 1 h of observation. Therefore, these results point to
the conclusion that the combined effect of SM and Chol may inhibit
the disrupting effect of 100 μM ODPC upon ﬂuid bilayers.
3.2. Lo–Ld phase coexistence
Focusing now our attention on GUVs that displayed liquid order
(Lo)–liquid disorder (Ld) coexistence, we investigated membranes
composed of DOPC:SM:Chol (1:1:1) [22]. Fig. 3 shows a set of GUVs
in phase contrast (a) and ﬂuorescence (b) modes to emphasize the
coexistence of Ld–Lo lipid phase on the prepared membrane. The
bright regions on ﬂuorescent GUVs (Fig. 4b) correspond to Ld phases
where the ﬂuorophore Rh-DOPE is preferentially located [23].
Interestingly, by adding 100 μM ODPC to these GUVs the domains
rapidly disappeared in less than 1 min of contact. This result is shown
in Fig. 4, which presents a time evolution of a GUV starting from
3 min of ODPC incubation (Fig. 4a–b), with abolition of Lo–Ld phase
separation indicated by the homogeneous ﬂuorescence distribution on
the membrane surface. Of course, nanodomains may still exist but
they are not observable due to the optical resolution of 1 μm. However,
after 14 min of ODPC–membrane interaction (Fig. 4d) the domains
started to reappear, becoming evident at 18 min of ODPC contact
(Fig. 4e). Extensive lipid reorganization in themembrane was observed
with time until two large separated ﬂuid domains are observed on the
membrane surface after 26 to 30 min of ODPC interaction (Fig. 4g–h).
More intriguing, the GUV exploded suddenly in the time sequence, as
shown in the last snapshots (Fig. 4l–m).
In order to compare the ODPC action mechanism with that of
perifosine on lipid rafts, we also performed GUVs experiments with
100 μM perifosine. Fig. 5 shows the results for a representative GUV.
Similarly to ODPC, perifosine also disrupts Lo–Ld phase coexistence
in less than 1 min. On the other hand, just a subtle tendency of lipid
reorganization is identiﬁed as small bright dots on the membrane
contour at 20 min of perifosine incubation (Fig. 5f), followed by
membrane shrinking (Fig. 5h–i) and bursting (Fig. 5j).
Noteworthy, it has been proposed for edelfosine that its mechanism
of action is mediated by the high afﬁnity of the ALP molecule for Chol
present in raft domains, leading to a redistribution of Chol from the
plasma membrane to the cells after edelfosine treatment [10,11]. As a
consequence, changes in the raft composition in terms of lipids and
proteins must take place. We demonstrated here that the lipid raft-
containing model membrane responds to ODPC action in three distinctb
hase contrast and (b) ﬂuorescence microscopy. The ﬂuorescent dye, Rh-DOPE, partitions
to 20 μm.
Fig. 4. Images obtained in phase contrast (a, i, j–m) and ﬂuorescence (b–h) modes from a GUV composed of DOPC:SM:Chol (1:1:1) showing the effect of 100 μM ODPC upon the
lipid membrane until its disruption. The ﬂuorescent dye, Rh-DOPE, partitions preferentially into the liquid disordered phase [23]. Objective 60×. The scale bar corresponds to 20 μm.
The beginning of ODPC-membrane interaction was set as time 0 min. Time sequence: (a–b) 3 min; (c) 10 min; (d) 14 min; (e) 18 min; (f) 22 min; (g) 26 min; (h–i) 30 min;
(j) 35 min; (l–m) 36 min.
1387A.B. Gomide et al. / Biochimica et Biophysica Acta 1828 (2013) 1384–1389steps: i) the ODPCmolecule initially provokes a disturbance in the lipid
domains by favoring lipid mixing in a fast way (less than 1 min), as
shown in GUVs composed of DOPC:SM:Chol (1:1:1) (Fig. 4). Probably,Fig. 5. Images obtained in phase contrast (a, g–j) and ﬂuorescence (b–f) modes from a GUV
lipid membrane until its disruption. The ﬂuorescent dye, Rh-DOPE, partitions preferentially i
The beginning of perifosine–membrane interaction was set as time 0 min. Time sequence: (
(j) 26 min.its insertion in the membrane alters the phase boundaries of the lipid
mixture of DOPC, SM and Chol, by lowering the miscibility transition
temperature Tmix [22]; ii) the lipids subsequently segregate to liquidcomposed of DOPC:SM:Chol (1:1:1) showing the effect of 100 μM perifosine upon the
nto the liquid disordered phase [23]. Objective 60×. The scale bar corresponds to 10 μm.
a–b) 3 min; (c) 6 min; (d) 10 min; (e) 17 min; (f–g) 20 min; (h) 22 min; (i) 25 min;
Fig. 6. Proposed mechanism of alkylphospholipids (here represented by ODPC) that induces raft disorganization. (a) Assembly of lipid rafts containing domains of varying orders
and compositions (TM-protein: transmembrane protein). (b) Treatment with ODPC disrupts the assembly of lipid-rafts, resulting in a displacement of raft-associated proteins.
ODPC-induced modiﬁcations in the plasma membrane, by which lateral organization and ﬂuidity are compromised, may lead to cell death.
1388 A.B. Gomide et al. / Biochimica et Biophysica Acta 1828 (2013) 1384–1389domainswithin 14–18 min (Fig. 4d–e), reﬂecting that the homogenous
phase was not thermodynamically stable. Thus, the pseudo-ternary ho-
mogeneous phase should be very close to the boundary of one-liquid
phase to coexisting liquid phases transition; iii) the lipids continue to
evolve into two segregated ﬂuid domains (Fig. 4f–h); this redistribution
of lipids in the membrane leads to rupture of the GUVs (last panels on
Fig. 4l–m).
Membrane domain-disrupting effects have also been recently
reported for cholesterol derivatives [28] and vitamin E [29]. In the latter
case, Muddana et al. [29] showed by coarse-grainedmolecular dynamic
simulation that vitamin E acts as a linactant, partitioning preferentially
to the domain boundaries and lowering the tendency for domain for-
mation. New experiments using a ﬂuorescent probe linked to ODPC
are currently in progress in our lab to conﬁrm the preferential partition
of the ALP in the rafts boundaries. On the other hand, Carrer et al. [28]
measured the lipid diffusion coefﬁcient of some Chol-derivatives by
ﬂuorescence correlation spectroscopy and demonstrated that these
Chol analogs contribute to an increase in the diffusion coefﬁcients,
favoring the lipid mixing into the membrane. Furthermore, monolayer
experiments performed with SM:Chol raft-like domains demonstrated
that edelfosine has a ﬂuidizing effect on the mixed system [30]. Based
on this ﬁnding, we may think that ODPC has a similar effect on lipid
bilayers, in such a way that it may promote changes in the ﬂuidity of
the membrane, as also previously revealed by DSC for ODPC interaction
with DPPC membranes [19], favoring initially the lipid mixing.
Despite the fact that perifosine also disrupts the lipid domains, such
as ODPC, it must promote changes in the membrane properties to a
larger extent than does ODPC. Perifosine must diminish Tmix more
than ODPC, by increasing the membrane ﬂuidity. As a consequence,
the new formed homogenous ﬂuid phase must be placed far from the
pseudo-ternary phase transition boundary [22]. Nevertheless, the
perifosine-containing membrane also becomes unstable over time
until its total destruction. So far, there is no report in the literature
about the action mechanism of ALPs upon lipid membranes that
resulted in lipid de-mixing followed by membrane disruption as re-
vealed in the present work.
It must be emphasized, however, that the initial stage of lipid
raft-disruption by both ODPC and perifosine, and maybe other ALPs, by
promoting lipid mixing, may be correlated with their toxicity upon neo-
plastic cells. Accordingly, changes in the lipid bilayer biophysical proper-
ties have been demonstrated to trigger signaling pathways [31]. As a
consequence, selective (dis)association of essential proteins within lipid
raft scaffolds must take place. AKT/PI3K cell signaling disruption by ALPs
has been observed probably due to a primary action of the APLs on the or-
ganization of lipids in rafts and raft-associated proteins, as an exampleNTAL/LAB2with function seems to be consequently altered [20]. Previous
studies indicated that ODPC interferes with the interaction of lipid rafts
and adaptor proteins in cells, which leads to an inefﬁcient scaffold for
signal transduction proteins. In particular, raft-transmembrane proteins
which present palmitoylation sites (Fig. 6) decreased in abundance after
ODPC treatment of leukemic cells [20]. Palmitoylation regulates raft afﬁn-
ity for the majority of integral raft proteins [32].
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